Back
Meta Platforms Vs. Akero Therapeutics Industry Stock Comparison
Buy
85
META
Meta Platforms
Last Price:
$686.81
Seasonality Move:
7.79%
Buy
57
AKRO
Akero Therapeutics
Last Price:
$55.30
Seasonality Move:
-13.54%
Buy
85
Meta Platforms (META)
is a Buy
Is Meta Platforms a Buy, Sell or Hold?
-
The current Meta Platforms [META] share price is $676.49. The Score for META is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
META is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.00. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms's stock price today?
-
The Meta Platforms share price today is $676.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
META Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.22 | Buy |
Relative Strength Index (14 RSI): | 71.87 | Buy |
Chaikin Money Flow: | 6666002 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (592.8 - 641.58) | Buy |
Bollinger Bands (100): | (552.09 - 618.79) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.24 | Buy |
Relative Strength Index (14 RSI): | 85.85 | Buy |
Chaikin Money Flow: | 423269 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.76 - 38.18) | Buy |
Bollinger Bands (100): | (24.88 - 34.36) | Buy |
META Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 643.42 | Buy |
20-day SMA: | 621.68 | Buy |
50-day SMA: | 605.05 | Buy |
200-day SMA: | 538.83 | Buy |
8-day EMA: | 649.88 | Buy |
20-day EMA: | 629.85 | Buy |
50-day EMA: | 609.6 | Buy |
200-day EMA: | 541.26 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.66 | Buy |
20-day SMA: | 29.67 | Buy |
50-day SMA: | 29.97 | Buy |
200-day SMA: | 26.38 | Buy |
8-day EMA: | 39.78 | Buy |
20-day EMA: | 32.93 | Buy |
50-day EMA: | 30.49 | Buy |
200-day EMA: | 28.24 | Buy |
Meta Platforms Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.78 per share, and an increase next year of $3.46 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and an increase next year of $0.08 per share.
Meta Platforms Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |